Sernova (Sernova) Net Margin % : 0.00% (As of Jan. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Sernova Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Sernova's Net Income for the three months ended in Jan. 2024 was $-7.26 Mil. Sernova's Revenue for the three months ended in Jan. 2024 was $0.00 Mil. Therefore, Sernova's net margin for the quarter that ended in Jan. 2024 was 0.00%.

The historical rank and industry rank for Sernova's Net Margin % or its related term are showing as below:

SEOVF's Net Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -155.67
* Ranked among companies with meaningful Net Margin % only.

Sernova Net Margin % Historical Data

The historical data trend for Sernova's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Net Margin % Chart

Sernova Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Net Margin %

Get a 7-Day Free Trial

Sernova Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Net Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Sernova's Net Margin %

For the Biotechnology subindustry, Sernova's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sernova's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova's Net Margin % distribution charts can be found below:

* The bar in red indicates where Sernova's Net Margin % falls into.

Sernova Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Sernova's Net Margin for the fiscal year that ended in Oct. 2023 is calculated as

Net Margin	=	Net Income (A: Oct. 2023 )	/	Revenue (A: Oct. 2023 )
	=	-28.441	/	0
	=	%

Sernova's Net Margin for the quarter that ended in Jan. 2024 is calculated as

Net Margin	=	Net Income (Q: Jan. 2024 )	/	Revenue (Q: Jan. 2024 )
	=	-7.258	/	0
	=	%

Sernova (OTCPK:SEOVF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Sernova Net Margin % Related Terms

Thank you for viewing the detailed overview of Sernova's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sernova (Sernova) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Corp (OTCPK:SEOVF) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

PSH:Germany SVA:Canada

Address

700 Collip Circle, The Stiller Centre, Suite 114, London, ON, CAN, N6G 4X8

Website

https://www.sernova.com

Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and or hormones for the long-term treatment of multiple serious, chronic diseases such as diabetes, hemophilia, and thyroid disease.